Prader-Willi Syndrome and Genetic Forms of Diabetes Group

Publications

Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)

Kumar, S. S.; McManus, H.; Radovich, T.; Greenfield, J. R.; Viardot, A.; Williams, K. M.; Cronin, P.; Day, R. O.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2018

Prader-willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance

Viardot, A.; Sze, L.; Purtell, L.; Sainsbury, A.; Loughnan, G.; Smith, E.; Herzog, H.; Steinbeck, K.; Campbell, L. V.;

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95(7):3392-9, 2010

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

Chambers, E. S.
; Viardot, A.
; Psichas, A.
; Morrison, D. J.
; Murphy, K. G.
; Zac-Varghese, S. E.
; MacDougall, K.
; Preston, T.
; Tedford, C.
; Finlayson, G. S.
; Blundell, J. E.
; Bell, J. D.
; Thomas, E. L.
; Mt-Isa, S.
; Ashby, D.
; Gibson, G. R.
; Kolida, S.
; Dhillo, W. S.
; Bloom, S. R.
; Morley, W.
; Clegg, S.
; Frost, G.;

GUT 64(11):1744-54, 2015

The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes

Viardot, A.; Lord, R. V.; Samaras, K.;

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 95(6):2845-50, 2010

Obesity is associated with activated and insulin resistant immune cells

Viardot, A.; Heilbronn, L. K.; Samocha-Bonet, D.; Mackay, F.; Campbell, L. V.; Samaras, K.;

DIABETES-METAB RES 28(5):447-54, 2012

Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes

Viardot, A.;Heilbronn, L. K.;Herzog, H.;Gregersen, S.;Campbell, L. V. :

INTERNATIONAL JOURNAL OF OBESITY 32(6):943-8, 2008